Not applicableStudy completedNCT01666145What this trial is testingAdvanced Image Guidance Utilized in Liver SurgeryWho this might be right forCarcinoma, Hepatocellular Wake Forest University Health Sciences 14
Not applicableStudy completedNCT00950144What this trial is testingStudying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver CancerWho this might be right forColorectal CancerDepressionFatigue+3 more City of Hope Medical Center 123
Testing effectiveness (Phase 2)Study completedNCT00107536What this trial is testingLapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+5 more National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT05822752What this trial is testingStudy to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma AbbVie 130
Not applicableStudy completedNCT02072486What this trial is testingSorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forAdvanced Adult Hepatocellular CarcinomaLocalized Non-Resectable Adult Hepatocellular CarcinomaStage III Childhood Hepatocellular Carcinoma+6 more Roswell Park Cancer Institute 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06109272What this trial is testingAssess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)Who this might be right forHepatocellular Carcinoma AbbVie 89
Early research (Phase 1)Study completedNCT01075113What this trial is testingSorafenib and Vorinostat in Treating Patients With Advanced Liver CancerWho this might be right forLiver Cancer Virginia Commonwealth University 16
Testing effectiveness (Phase 2)Looking for participantsNCT04803318What this trial is testingTrametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid TumorsWho this might be right forSolid Tumor, AdultHepatocellular Carcinoma Second Affiliated Hospital of Guangzhou Medical University 100
Early research (Phase 1)Study completedNCT00005860What this trial is testingOxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00128596What this trial is testingArsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forLiver Cancer University of Pittsburgh 25
Testing effectiveness (Phase 2)Study completedNCT00052364What this trial is testingOxaliplatin in Treating Patients With Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 32
Testing effectiveness (Phase 2)WithdrawnNCT00093548What this trial is testingVaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver CancerWho this might be right forLiver Cancer Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00030082What this trial is testingHepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver CancerWho this might be right forLiver CancerMetastatic Cancer National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00012324What this trial is testingNolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver CancerWho this might be right forLiver Cancer Eximias Pharmaceutical
Not applicableStudy completedNCT04576572What this trial is testingComparison of Criteria for Liver Transplantation in Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaLiver CancerAdvanced Adult Hepatocellular Carcinoma+3 more Inonu University 424
Testing effectiveness (Phase 2)Study completedNCT00321594What this trial is testingBelinostat in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00238394What this trial is testingCediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00608361What this trial is testingDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more National Cancer Institute (NCI) 80
Testing effectiveness (Phase 2)Study completedNCT00639509What this trial is testingIMC-A12 in Treating Patients With Advanced Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 24